Agreements Announced on Surfactant Protein-B Diagnostic Applications

摘要

Roche Diagnostics and Australian Biotech company SMD, Southern Medical Diagnostics, have announced the signing of license agreements which provide Roche Diagnostics with semi-exclusive worldwide rights for diagnostic applications of Surfactant Protein-B in lung disorders and SMD with world-wide rights to key test components developed by Roche which SMD may exclusively apply for Surfactant Protein-B applications.